Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial

Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial

Abstract Background In a randomized trial, Lianhuaqingwen (LHQW) capsule was effective for accelerating symptom recovery among patients with coronavirus disease 2019 (COVID-19). However, the lack of blinding and limited sample sizes decreased the level of clinical evidence. Objectives To evaluate th...

Full description

Bibliographic Details
Main Authors: Jin-ping Zheng, Yun Ling, Liang-shuang Jiang, Piroon Mootsikapun, Hong-zhou Lu, Methee Chayakulkeeree, Li-xiu Zhang, Pureepat Arttawejkul, Feng-yu Hu, Thi Ngoc Lan Truong, Roxan A. Perez, Xing Gu, Hui-min Sun, Jian-jie Jiang, Ren-jie Liu, Zhen Ding, Yang-qing Zhan, Zi-feng Yang, Wei-jie Guan, Nan-shan Zhong
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Virology Journal
Subjects:
Coronavirus disease 2019
Omicron
Lianhuaqingwen Capsule
Symptom resolution
Inflammation
Online Access:https://doi.org/10.1186/s12985-023-02144-6

Internet

https://doi.org/10.1186/s12985-023-02144-6

Similar Items